In the realm of biochemical research and gut physiology, plasma peptide YY (PYY) has emerged as a focal point for those interested in the intricate signaling pathways of the digestive system. As someone who follows peptide research closely, I have found that tracking the nuances of this specific 36-amino acid peptide offers a fascinating look at how our internal systems manage energy homeostasis.
The Biological Role of PYY
Peptide YY is a hormone made in the small intestine, specifically synthesized and released from endocrine L cells located in the ileum and colon. When we look at the physiological landscape, it is clear why PYY is considered a gut peptide of significant interest. It acts as a chemical messenger that communicates with the brain and other digestive organs to modulate various functions.
One of the most documented aspects of this molecule is that PYY is anorexigenic and inhibits feedi Effect of Peptide YY 3–36 on Food Intake in Humans ng stimuli after a meal, effectively acting as a natural brake on energy intake. For those exploring the literature, you will find that PYY has been shown to inhibit gastric acid secretion and emptying, which plays a critical role in how the body processes nutrients.
Plasma PYY Dynamics and Nutrient Intake
A key observation in my research is that plasma PYY concentrations increased in response to food intake reflecting the size of the calorie load. Typically, plasma PYY levels increase within 15 min after nutrient consumption, peak at about 60–90 min, and can remain elevated for up to 6 hours. Interestingly, the plasma concentration of PYY3–36 increases shortly after nutrient intake and even before nutrients fully reach the PYY-producing cells in the distal gut.
Furthermore, PYY concentrations are proportional to meal energy content, demonstrating a precise feedback loop. It is also worth noting that total secretion of PYY is higher in females than in males, an observation that highlights the variability in endocrin Learn about the Peptide YY (PYY) test, its role in digestion, and clinical significance. Order now with Inter School Institute with code PYY. e responses.
Distinguishing PYY Forms: PYY(1-36) vs. PYY(3-36)
When discussing this subject, it is vital to distinguish between the various forms. The Peptide YY (3–36) form is particularly noted for its role in signaling. Researchers have observed that reduced short-term food intake by up to 50% has been reported in models using this specific truncated form. Because of its potency, Peptide YY (3–36) is a compound being evaluated for the treatment of obesity, as it mimics the body's natural postprandial signaling.
Research and Clinical Significance
For those who want to learn about the Peptide YY (PYY) test, it is primarily used in clinical settings to assess gut hormone function. Historically, Peptide YY levels were found to be grossly elevated in patients with specific malabsorption issues, such as steatorrhea.
In the modern research landscape, PYY is a potential treatment for type 2 diabetes mellitus because of its ability to influence insulin secretion and delay gastric emptying. While plasma PYY levels after consuming a mixed meal are significantly re by NT Nguyen · 2025 · Cited by 3 — For example, plasma PYY levels after consuming a mixed meal are significantly reduced in subjects with T2D compared to non-diabetic controls, indicating a duced in some metabolic conditions compared to healthy controls, the ongoing study of PYY by RA Lafferty · 2018 · Cited by 22 — The current study has demonstrated C-terminal degradation of the major recognised circulating forms of PYY, PYY(1–36) and PYY(3–36), in plasma. treatment could be beneficial to those who suffer from obesity.
Conclusion
From my perspective, the study of Peptide YY (PYY) remains one of the most promising areas for understanding the connection between gut motility and systemic energy balance. Whether it is the study of Neuropeptide Y receptors or the specific PYY receptor interactions, the complexity of this hormone continues to provide deep insights into how our bodies regulate the post-absorptive state. by RA Lafferty · 2018 · Cited by 22 — The current study has demonstrated C-terminal degradation of the major recognised circulating forms of PYY, PYY(1–36) and PYY(3–36), in plasma. By viewing PYY as a new gut hormone wit 5697 - Gene ResultPYY peptide YY [ (human)] h both paracrine and endocrine effects, we gain a better appreciation for the sophisticated signaling network tha Peptide YY (PYY) is coproduced with GLP-1 by endocrine L cells in the distal small intestine and the large intestine. Two biologically active forms of PYY, t governs Peptide YY in humans and its role in food ingestion, gut motility, and insulin secretion.